Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment

Frank W. Roemer, Colin G. Miller, Christine R. West, Mark T. Brown, Sarah P. Sherlock, Andrew J. Kompel, Luis E. Diaz, Nicholas Galante, M.D. Crema, Ali Guermazi

Seminars in Arthritis and Rheumatism · 2017 · 13 citations · 22 references

Concepts

References

22